The devotion to surrogate outcomes in drug development for liver disease
Crossref DOI link: https://doi.org/10.1038/nrgastro.2017.155
Published Online: 2017-11-29
Published Print: 2018-01
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Rowe, Ian A.
Text and Data Mining valid from 2017-11-29
Article History
First Online: 29 November 2017
Competing interests
: I.A.R. has received honoraria for speaking at sponsored meetings from AbbVie and Bayer Healthcare outside the submitted work.